FIELD: veterinary medicine; ophthalmology.
SUBSTANCE: invention is intended for the treatment of diffuse catarrhal keratitis and catarrhal conjunctivitis in domestic and farm animals caused by exogenous or endogenous infectious factors leading to clouding of the cornea of the eye. An anti-inflammatory agent for the treatment of diffuse catarrhal keratitis and catarrhal conjunctivitis in veterinary medicine contains n-hexadecyltriphenylphosphonium bromide, 4,6-dichloronitrobenzofuroxan, alcohol tincture of catnip, lidocaine hydrochloride, a pharmaceutically acceptable carrier in the following ratio of components, wt.%: n-hexadecyltriphenylphosphonium bromide — 0,0000001; 4,6-dichlorobenzofuroxan — 0.0001; alcohol tincture of catnip — 0.5; lidocaine hydrochloride — 0.5; the rest is a pharmaceutically acceptable carrier.
EFFECT: above-described remedy expands the arsenal of means for this purpose by developing an anti-inflammatory agent for the treatment of diffuse catarrhal keratitis and catarrhal conjunctivitis in veterinary medicine in the form of eye drops and ointments that have low therapeutic doses of active substances, anti-inflammatory effects, and analgesic effects.
3 cl, 1 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
MEDICATION FOR TREATING DISEASES IN VETERINARY BASED ON PHOSPHONIUM SALT | 2009 |
|
RU2423131C2 |
AGENT FOR TREATING INFLAMMATORY EYE DISEASES IN VETERINARY BASED ON A PHOSPHONIUM SALT AND CHLORONITROBENZOFUROXANES | 2020 |
|
RU2736054C1 |
VETERINARY HYGIENIC EYE LOTION | 2022 |
|
RU2785343C1 |
ANTI-INFLAMMATORY EYE DROPS FOR PETS AND FARM ANIMALS | 2022 |
|
RU2780109C1 |
WOUND COVERING WITH ANTIBACTERIAL, ANTIMYCOTIC AND WOUND-HEALING EFFECTS AND METHOD OF ITS PREPARATION | 2023 |
|
RU2808334C1 |
ANTISEPTIC POWDER FOR VETERINARY MEDICINE BASED ON QUATERNARY PHOSPHONIUM SALT AND CHLORNITROBENZOFUROXANS | 2022 |
|
RU2786241C1 |
METHOD OF TREATING CATTLE THELAZIOSIS IN FIELD CONDITIONS | 2019 |
|
RU2717643C1 |
PHARMACEUTICAL COMPOSITION FOR VETERINARY MEDICINE AND MEDICINE WITH ANTIPARASITIC EFFICACY | 2022 |
|
RU2802022C1 |
OPHTHALMIC COMPOSITION FOR TREATMENT OF CONJUNCTIVITES, BLEPARITIS AND MARGINAL CORNEAL ULCERS IN TOPICAL APPLICATION | 2016 |
|
RU2633055C1 |
ANTIBACTERIAL DRUG IN FORM OF OINTMENT FOR TREATING EYE DISEASES IN ANIMALS | 2015 |
|
RU2580631C1 |
Authors
Dates
2023-12-05—Published
2023-05-31—Filed